DA
ZBH icon

Denali Advisors’s Zimmer Biomet ZBH Stock Holding History

Denali Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-24,617
Closed -$2.25M – 312
2015
Q3 		$2.25M Buy
24,617
+10,094
+70% +$1.01M 0.52% 64
2015
Q2 		$1.54M Buy
+14,523
New +$1.61M 0.34% 79

Other funds holding ZBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Denali Advisors's ZBH Position: Q4 2015 in Review

Denali Advisors sold out of Zimmer Biomet (ZBH) in Q4 2015, closing a stake of 24,617 shares — an estimated $2.25M sold.

Denali Advisors first reported a position in ZBH in Q2 2015 and held it in 2 quarters. The position peaked at $2.25M in Q3 2015. 739 funds tracked by Wall St. Rank hold ZBH as of Q4 2015.

  • Denali Advisors reported no remaining Zimmer Biomet position as of Q4 2015 after selling out during the quarter.
  • Denali Advisors sold 24,617 Zimmer Biomet shares in Q4 2015, an estimated $2.25M.
  • Denali Advisors first reported a position in Zimmer Biomet in Q2 2015 and held it in 2 quarters.
  • Denali Advisors's Zimmer Biomet position peaked at $2.25M in Q3 2015.
  • 739 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2015.

Based on Denali Advisors's 13F filing for Q4 2015, filed 7 Jan 2016.